what are the doses for tirzepatide compound How Many Units Is 2.5 mg of Tirzepatide? Conversion Chart All | Flow Wellness Tirzepatide dosage chart for weight

RCT SUMMIT - Tirzepatide vs Placebo for Heart Failure with Preserved Ejection Fraction and Obesity, NEJM (2024) [PubMed abstract] The SUMMIT trial enrolled 731 patients with heart failure, an ejection fraction of at least 50%, and a BMI of 30 or more Main inclusion criteria Age 40 years NYHA class II-IV EF 50% BMI 30 KCCQ-CSS of 80 or lower Main exclusion criteria Cardiomyopathy Uncontrolled hypertension History of bariatric surgery HbA1c 9.5% Baseline characteristics Age - 65.3 years Female sex - 53.8% NYHA class: II - 72.5% | III or IV - 27.5% Average body weight - 227 lbs (103 kg) Average BMI - 38.3 Average EF - 60.8% History of CAD - 30% Median NT-proBNP level - 183 pg/ml Average GFR - 64.4 ml/min Average KCCQ-CSS score - 53.6 Heart failure exacerbation within 12 months - 46.9% Atrial fibrillation - 25.5% Type 2 diabetes - 48.2% Randomized treatment groups Group 1 (364 patients): Tirzepatide with a target dose of 15 mg once weekly Group 2 (367 patients): Placebo Tirzepatide was started at 2.5 mg once weekly and increased by 2.5 mg every 4 weeks as tolerated (1) Composite of adjudicated death from cardiovascular causes or a worsening heart-failure event

But it also means that small measurement errors translate to larger dosing mistakes

Pregnancy and lactation Do not use Sejaro, if you are pregnant, think you may be pregnant or are planning pregnancy, because it is not known whether it can affect the development of your unborn baby

Understanding brand-name Mounjaro costs helps put compounded pricing in perspective

Alternative approaches Standard titration with GI support: Start at the standard 2.5 mg and use anti-nausea strategies (ginger, small meals, hydration, timing injections at bedtime) to manage side effects rather than avoiding them through lower doses

The trial data show population-level trends, but youre not a population average